These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 565357)

  • 1. Reconstitution of the ribonucleotide reductase enzyme from Ehrlich tumor cells.
    Cory JG; Fleischer AE; Munro JB
    J Biol Chem; 1978 May; 253(9):2898-901. PubMed ID: 565357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
    Cory JG; Fleischer AE
    Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoordinate changes in the components of ribonucleotide reductase in mammalian cells.
    Cory JG; Fleischer AE
    J Biol Chem; 1982 Feb; 257(3):1263-6. PubMed ID: 7035447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of ribonucleotide reductase from Ehrlich tumor cells; multiple nucleoside diphosphate activities and reconstitution of activity from components.
    Cory JG
    Adv Enzyme Regul; 1978; 17():115-31. PubMed ID: 757310
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivatives of adenosine, adenosine 5'-monophosphate, and adenosine 5'-triphosphate.
    Cory JG; Mansell MM
    Cancer Res; 1975 Feb; 35(2):390-6. PubMed ID: 1109803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular weight of Ehrlich tumor cell ribonucleotide reductase and its subunits: effector-induced changes.
    Cory JG; Fleischer AE
    Arch Biochem Biophys; 1982 Sep; 217(2):546-51. PubMed ID: 6753748
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleoside 5'-triphosphate analogs as positive and negative effectors of mammalian ribonucleotide reductase.
    Cory JG; Sato A; Bacon PE; Rey DA
    Cancer Biochem Biophys; 1985 Jun; 8(1):23-8. PubMed ID: 3896468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uridine diphosphate reductase of Ehrlich ascites tumor is insensitive to hydroxyurea.
    Murayama J; Morita T; Fukui N; Moriyama Y; Fujimura S
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1104-8. PubMed ID: 3884001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of ribonucleotide reductase in mammalian cells.
    Cory JG; Mansell MM; Whitford TW
    Adv Enzyme Regul; 1976; 14():45-62. PubMed ID: 987694
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential substrate properties of mammalian ribonucleotide reductase.
    Cory JG; Cory AH; Downes DL
    Adv Exp Med Biol; 1994; 370():631-5. PubMed ID: 7660984
    [No Abstract]   [Full Text] [Related]  

  • 11. Flavodoxin is required for the activation of the anaerobic ribonucleotide reductase.
    Bianchi V; Eliasson R; Fontecave M; Mulliez E; Hoover DM; Matthews RG; Reichard P
    Biochem Biophys Res Commun; 1993 Dec; 197(2):792-7. PubMed ID: 8267617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two additional glutaredoxins exist in Escherichia coli: glutaredoxin 3 is a hydrogen donor for ribonucleotide reductase in a thioredoxin/glutaredoxin 1 double mutant.
    Aslund F; Ehn B; Miranda-Vizuete A; Pueyo C; Holmgren A
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9813-7. PubMed ID: 7937896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
    Cory JG; Fleischer AE
    Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribonucleotide reductase of Brevibacterium ammoniagenes is a manganese enzyme.
    Willing A; Follmann H; Auling G
    Eur J Biochem; 1988 Jan; 170(3):603-11. PubMed ID: 2828045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleotide reductase from Escherichia coli: demonstration of a highly active form of the enzyme.
    Eriksson S
    Eur J Biochem; 1975 Aug; 56(1):289-94. PubMed ID: 240707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site of ribonucleoside diphosphate reductase from Escherichia coli. Inactivation of the enzyme by 2'-substituted ribonucleoside diphosphates.
    Thelander L; Larsson B
    J Biol Chem; 1976 Mar; 251(5):1398-405. PubMed ID: 767333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonucleotide reductase: association of the regulatory subunit in the presence of allosteric effectors.
    Klippenstein GL; Cory JG
    Biochem Biophys Res Commun; 1978 Jul; 83(1):252-8. PubMed ID: 697814
    [No Abstract]   [Full Text] [Related]  

  • 18. Half-site reactivity of the tyrosyl radical of ribonucleotide reductase from Escherichia coli.
    Sjöberg BM; Karlsson M; Jörnvall H
    J Biol Chem; 1987 Jul; 262(20):9736-43. PubMed ID: 3298261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of ribonucleoside diphosphate reductase from Escherichia coli. Evidence for 3'-C--H bond cleavage.
    Stubbe J; Ator M; Krenitsky T
    J Biol Chem; 1983 Feb; 258(3):1625-31. PubMed ID: 6337142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of normal and mutant protein M1 subunits of deoxyGTP-resistant ribonucleotide reductase from mutant mouse lymphoma cells.
    Ullman B; Gudas LJ; Caras IW; Eriksson S; Weinberg GL; Wormsted MA; Martin DW
    J Biol Chem; 1981 Oct; 256(19):10189-92. PubMed ID: 7024266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.